MPL and autoimmune thrombocytopenic purpura: A combination of controlled vocabulary terms and free-text keywords relating to “systemic lupus erythematosus,” “immune thrombocytopenia,” “rituximab,” “belimumab,” and “thrombopoietin receptor agonists” was employed.